Ligand validation:6PS7

OLA: OLEIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6PS7_OLA_A_1227	14%	61%	0.268	0.847	0.5	0.98	-	1	0	0	85%	1
6PS7_OLA_A_1226	12%	59%	0.198	0.804	0.64	0.93	-	-	0	0	60%	1
6PS7_OLA_A_1218	11%	58%	0.201	0.784	0.62	0.97	-	-	0	0	60%	1
6PS7_OLA_A_1215	9%	66%	0.206	0.731	0.55	0.74	-	-	0	0	80%	1
6PS7_OLA_A_1224	9%	60%	0.199	0.793	0.72	0.81	-	-	0	0	40%	1
6PS7_OLA_A_1219	8%	60%	0.201	0.758	0.65	0.88	-	-	0	0	55%	1
6PS7_OLA_A_1217	7%	58%	0.159	0.705	0.66	0.96	-	-	0	0	45%	1
6PS7_OLA_A_1216	6%	56%	0.217	0.74	0.68	1	-	-	0	0	45%	1
6PS7_OLA_A_1222	5%	59%	0.218	0.7	0.63	0.93	-	-	0	0	55%	1
6PS7_OLA_A_1225	2%	63%	0.246	0.566	0.55	0.84	-	1	0	0	90%	1
6PS7_OLA_A_1223	2%	72%	0.25	0.608	0.39	0.7	-	-	0	0	45%	1
6PS7_OLA_A_1221	1%	58%	0.263	0.447	0.62	1	-	-	0	0	60%	1
6PS7_OLA_A_1220	0%	59%	0.315	0.43	0.61	0.97	-	-	0	0	65%	1
5IU4_OLA_A_2406	64%	62%	0.105	0.903	0.69	0.75	-	1	0	0	100%	1
8RWE_OLA_A_1206	62%	55%	0.123	0.914	0.79	0.95	1	1	1	0	100%	1
8RVW_OLA_A_1211	56%	54%	0.134	0.932	0.87	0.89	1	1	0	0	85%	1
8RW0_OLA_A_1218	53%	54%	0.125	0.902	0.82	0.94	1	-	1	0	90%	1
8RWC_OLA_A_1207	50%	54%	0.131	0.882	0.78	0.98	1	1	0	0	100%	1
6TPJ_OLA_B_2111	99%	74%	0.058	0.985	0.53	0.48	-	-	2	0	100%	1
4X9X_OLA_A_301	96%	67%	0.079	0.988	0.6	0.68	-	-	0	0	100%	1
7WE5_OLA_A_201	94%	74%	0.08	0.977	0.52	0.48	-	-	0	0	100%	0.764
6DJ6_OLA_B_402	92%	68%	0.081	0.971	0.55	0.69	-	-	0	0	100%	1
6LX8_OLA_A_502	89%	65%	0.079	0.956	0.65	0.7	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.